Search Results

Vinpocetine 10mg  | ≥99%

CSNpharm

Vinpocetine is a selective inhibitor for PDE1 with IC50 of 21 μM, it also blocks voltage-gated Na+ channels. It’s a natural product isolated and purified from the herbs of Catharanthus roseus (L.) G. Don.

More Information Supplier Page

KY 12420 10mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

KY 12420 5mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page

Wy-14643 50mg  | ≥99%

CSNpharm

Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..

More Information Supplier Page

Wy-14643 100mg  | ≥99%

CSNpharm

Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..

More Information Supplier Page

Wy-14643 10mg  | ≥99%

CSNpharm

Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..

More Information Supplier Page

Wy-14643 250mg  | ≥99%

CSNpharm

Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..

More Information Supplier Page

KY 12420 25mg  | ≥99%

CSNpharm

KY 12420 is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. It also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

More Information Supplier Page